0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Protein > BTLA > BTA-H52H5

Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified)

Order Now

  • Synonym
    BTLA,CD272
  • Source
    Human BTLA (31-150) (M105V, G138S, V148M), His Tag(BTA-H52H5) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Ser 150 (Accession # AAP44003.1 (M105V, G138S, V148M)).
  • Molecular Characterization
    BTLA Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 15.8 kDa. The protein migrates as 27-33 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
BTLA SDS-PAGE

Human BTLA (31-150) (M105V, G138S, V148M), His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

SEC-MALS
BTLA MALS images

The purity of Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) is more than 90% and the molecular weight of this protein is around 19-26 kDa verified by SEC-MALS.

Bioactivity-ELISA
 BTLA ELISA

Immobilized Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) at 5 μg/mL (100 μL/well) can bind Human HVEM, Fc Tag (Cat. No. HVM-H5258) with a linear range of 0.6-5 ng/mL (QC tested).

 BTLA ELISA

Immobilized Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) at 5 μg/mL (100 μL/well) can bind Human HVEM, Mouse IgG2a Fc Tag, low endotoxin with a linear range of 0.6-39 ng/mL (Routinely tested).

  • Background
    B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.
  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €350.00

Price(EUR) : €2670.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:5 Details
  • Latest Research Phase:Phase 3 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message